diaDexus, Inc.
diaDexus, Inc. was founded in 1997 and is based in South San Francisco, California. diaDexus, Inc., a biotechnology company, engages in the discovery, development, and commercialization of in vitro diagnostic products to address the medical needs in the cardiovascular field. The company develops The PLAC Test, a blood test to aid in assessing risk for coronary heart disease (CHD) and ischemic stroke associated with atherosclerosis. Its product measures lipoprotein-associated phospholipase A2 (Lp-PLA2), which is a vascular-specific inflammatory enzyme implicated in the formation of rupture-prone plaque. The company’s PLAC Test is available as an ELISA assay that runs on an automated micropate system, as well as in the form of immunotarbidimetric technology that runs on common clinical chemistry analyzers used in clinical reference laboratories, hospitals, and physician office laboratories.
Contact Details
Office Address
diaDexus, Inc.
343 Oyster Point Boulevard
South San Francisco, CA, USA 94080-1913
Phone: (650) 246-6400
Fax: (650) 246-6499
Executives
President, CEO, COO, and Director
Patrick Plewman
EVP and CFO
David J. Foster